To support research into coping with the corona virus pandemic, the Federal Ministry for Digital and Economic Affairs (BMDW) and the Federal Ministry for Climate Protection, Environment, Energy, Mobility, Innovation and Technology (BMK) provided funding to the FFG Austrian Research Promotion Agency for an Emergency Call Emergency Call in March 2020. The FFG funded experimental development R&D projects by individual Austrian companies dealing with corona virus and COVID-19 related issues that could be quickly implemented, including clinical trials and innovative manufacturing strategies in medically critical areas. The evaluation is intended to reflect the experiences with the administrative implementation of the Emergency Call as well as the results of the funding.
In cooperation with convelop cooperative knowledge design gmbh and the Bibliometrics and Publication Strategies unit of the University of Vienna library, inspire research evaluated the Alexander von Humboldt Foundation's Humboldt Research Fellowship Programme. The evaluation focused on the question of the extent to which the programme succeeds in attracting the best junior researchers and established researchers from abroad to spend a research fellowship in Germany. The evaluation also assessed the country-specific measures adopted by the Alexander von Humboldt Foundation to approach highly qualified researchers and discussd the attractiveness of alumni offers for Humboldt Research Fellows.
With the funding scheme Clinical Research Units (KFO), the German Research Foundation (DFG,) aims to improve and strengthen research-oriented structures at university medical institutions in Germany. Central aspects in this context are the development of a scientific profile and research priorities, the strengthening of cooperation between natural scientists and clinicians and the promotion of young researchers among clinicians. In the evaluation, inspire research analysed to which extent the goals of the funding instrument could be achieved. The evaluation shed light on the value added which the instrument continues to offer in comparison to other DFG funding schemes to improve research structures at university medical institutions.